Urgent window

ONDCP Model State Drug Law Initiative deadline 2013

The current listed application deadline is February 15, 2013. Use this page to verify timing fast, then move into the full grant record for planning, comparison, and drafting.

Agency
Office of National Drug Control Policy
Award range
Up to $1,250,000
Total funding
$1,250,000
Funding instrument
Grant
CFDA / ALN
95.006
Cost share
No

Deadline Status

This deadline has passed

Review the full grant record for updated cycles, archived guidance, and adjacent opportunities.

Quick facts

Opportunity number
ONDCP-STATEDRUGLAW-2013
Last updated
January 17, 2013
Expected awards
1

Deadline summary

OVERVIEW With the release of President Obama’s first National Drug Control Strategy in 2010, the Office of National Drug Control Policy (ONDCP) has been coordinating a government-wide public health and public safety approach to reduce drug use and its consequences in the United States. The Obama Administration recognizes that drug use is a threat to the Nation’s public health, and that drug addiction is a preventable and treatable disease. ONDCP pursues a balanced and comprehensive app...

Key dates

Posted
January 14, 2013
Deadline
February 15, 2013

Before you apply

Confirm the official submission path and any portal requirements.
Review the close date carefully and account for agency timezone handling.
Validate fit against the listed eligibility groups before investing drafting time.
This program expects about 1 awards, which can help frame competitiveness.

Eligibility snapshot

12Applicant Eligibility (081): Applicants must have expert knowledge and extensive experience in conducting research and analysisproviding technical assistanceand drafting model state drug and alcohol lawspolicies and programs as established by PL109-469Section 1105

Applicant Eligibility (081): Applicants must have expert knowledge and extensive experience in conducting research and analysis, providing technical assistance, and drafting model state drug and alcohol laws, policies and programs as established by PL109-469, Section 1105, MODEL ACTS and in accordance with the President’s Commission on Model State Drug Laws in 1993.